Lindbrook Capital’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $858 | Buy |
117
+49
| +72% | +$359 | ﹤0.01% | 2505 |
|
|
2024
Q4 | $581 | Hold |
68
| – | – | ﹤0.01% | 2584 |
|
|
2024
Q3 | $592 | Hold |
68
| – | – | ﹤0.01% | 2621 |
|
|
2024
Q2 | $465 | Buy |
+68
| New | +$465 | ﹤0.01% | 2618 |
|
|
2023
Q3 | – | Sell |
-401
| Closed | -$2.07K | – | 2802 |
|
|
2023
Q2 | $2.07K | Hold |
401
| – | – | ﹤0.01% | 2137 |
|
|
2023
Q1 | $2.11K | Buy |
+401
| New | +$2.11K | ﹤0.01% | 2223 |
|
|
2022
Q4 | – | Sell |
-677
| Closed | -$3K | – | 2972 |
|
|
2022
Q3 | $3K | Buy |
+677
| New | +$3K | ﹤0.01% | 1903 |
|
|
2021
Q4 | – | Sell |
-5,900
| Closed | -$59K | – | 2175 |
|
|
2021
Q3 | $59K | Sell |
5,900
-2,300
| -28% | -$23K | 0.02% | 400 |
|
|
2021
Q2 | $116K | Buy |
8,200
+1,000
| +14% | +$14.1K | 0.03% | 263 |
|
|
2021
Q1 | $118K | Buy |
7,200
+3,452
| +92% | +$56.6K | 0.03% | 243 |
|
|
2020
Q4 | $78K | Buy |
3,748
+748
| +25% | +$15.6K | 0.02% | 287 |
|
|
2020
Q3 | $23K | Sell |
3,000
-2,478
| -45% | -$19K | 0.01% | 569 |
|
|
2020
Q2 | $46K | Buy |
5,478
+4,478
| +448% | +$37.6K | 0.01% | 372 |
|
|
2020
Q1 | $5K | Buy |
+1,000
| New | +$5K | ﹤0.01% | 1006 |
|